CNO Financial Group, Inc. (CNO) — Fair Value Analysis
Base-case fair value (P50): $33.26 · Current price: $44.63 · Verdict: Overvalued
The Verdict on CNO
CNO Financial Group Inc (CNO) currently appears Overvalued according to our latest Monte Carlo simulations. The stock is trading at $44.63, while our median fair value (P50) for CNO is calculated to be $33.26. This substantial difference implies a -25.5% downside potential relative to the current market price, suggesting the market has priced in more optimism than fundamental analysis warrants. Our simulations, which run thousands of forward scenarios, consistently point to this overvaluation, signaling a significant divergence between the present trading level and the intrinsic value derived from a comprehensive range of financial inputs.
How CNO stacks up against peers
When assessing the current valuation of CNO at $44.63 against its median fair value of $33.26, it's crucial to consider the broader context. CNO is currently unrated in terms of its operational and financial health compared to its sector peers. This absence of a specific quality tier, coupled with the clear -25.5% overvaluation indicated by our Monte Carlo analysis, suggests investors should exercise particular diligence. The disparity between the current price and our fundamental assessment is notable, especially when the underlying operational strength relative to the sector remains undefined.
What this means for investors
For investors monitoring CNO, the stark contrast between the current trading price of $44.63 and our median fair value of $33.26 demands attention. The Monte Carlo analysis, which resulted in the Overvalued verdict, suggests that the present market premium is unsupported by the simulated financial outcomes, reinforcing the -25.5% implied downside. While our models incorporate a wide array of future possibilities, encompassing both more favorable bull cases and more challenging downside scenarios, the central tendency remains clear. Our FairCurve platform indicates that current price levels reflect an elevated risk profile, warranting a cautious approach to new positions or re-evaluating existing ones. Sign up for FairCurve to see the full bear/bull distribution and track CNO's fair value as new fundamentals are released.
Frequently Asked Questions
Is CNO overvalued or undervalued right now?
CNO is currently overvalued. Our median fair value estimate is $33.26, significantly below its current trading price of $44.63.
What is the bear case and bull case for CNO?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate CNO's fair value?
FairCurve calculates CNO's fair value using Monte Carlo simulations that model thousands of forward scenarios based on various financial inputs. This approach provides a robust estimate of intrinsic value.
How can I track CNO's fair value as it changes?
You can add CNO to a free FairCurve watchlist to receive daily fair-value updates. FairCurve will instantly re-value the stock when new earnings or significant fundamental data are released.